Published: 20 April 2015

Committees

Comments on Agenda Items for the 53rd meeting of the Medicines Classification Committee to be held on Tuesday 5 May 2015

A total of 20 submissions commenting on agenda items for the 53rd meeting were received (PDF Document, 6,681 KB, 100 pages).

Two comments were received regarding the request for confirmation that the pharmacy-only classification of azelastine for nasal use remains appropriate (agenda item 5.2).

Three comments were received regarding the availability of ketoprofen for topical use as a general sale medicine (agenda item 5.3).

One comment was received regarding the proposed reclassification of omeprazole from pharmacy-only to restricted medicine (agenda item 5.4).

Four comments were received regarding the proposed reclassification of paracetamol in combination with phenylephrine (agenda item 5.5).

One comment was received regarding the public consultation process (agenda item 5.6).

Ten comments were received regarding the proposed reclassification of nitrofurantoin from prescription to restricted medicine (agenda item 6.1).

Thirteen comments were received regarding the proposed reclassification of oral contraceptives from prescription to restricted medicine (agenda item 6.2).

One comment was received regarding the proposed classification of bilastine as a pharmacy-only medicine (agenda item 7.1).

Two comments were received regarding the proposed classification of otilonium bromide as a pharmacy-only medicine (agenda item 7.2).

Three submissions commenting on agenda items have not been published.